Evidence map›Paper›PMID 33038288›Full record

ArticleAngewandte Chemie (International ed. in English)2021

Azadiphosphaindane-1,3-diyls: A Class of Resonance-Stabilized Biradicals.

Jonas Bresien, Dirk Michalik, Axel Schulz, Alexander Villinger, Edgar Zander

Open access · hybridAbstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 21 citations in OpenAlex.

  1. Bond and Antibond Resonances: A Unified Framework for Singlet Biradical Character.Chemistry (Weinheim an der Bergstrasse, Germany) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Azadiphosphaindane-1,3-diyls: A Class of Resonance-Stabilized Biradicals.Angewandte Chemie (International ed. in English) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jonas BresienInstitut für Chemie, Universität Rostock, Albert-Einstein-Straße 3a, 18059, Rostock, Germany.ORCID http://orcid.org/0000-0001-9450-3407
Dirk MichalikInstitut für Chemie, Universität Rostock, Albert-Einstein-Straße 3a, 18059, Rostock, Germany.ORCID http://orcid.org/0000-0002-0285-2595
Axel SchulzInstitut für Chemie, Universität Rostock, Albert-Einstein-Straße 3a, 18059, Rostock, Germany.ORCID http://orcid.org/0000-0001-9060-7065
Alexander VillingerInstitut für Chemie, Universität Rostock, Albert-Einstein-Straße 3a, 18059, Rostock, Germany.ORCID http://orcid.org/0000-0002-0868-9987
Edgar ZanderInstitut für Chemie, Universität Rostock, Albert-Einstein-Straße 3a, 18059, Rostock, Germany.ORCID http://orcid.org/0000-0003-3396-7456
University of Rostock · DELeibniz Institute for Catalysis · DE

Funding

Deutsche Forschungsgemeinschaft SCHU/1170/12-2
6 · The paper itself

Abstract

Conversion of 1,2-bis(dichlorophosphino)benzene with sterically demanding primary amines led to the formation of 1,3-dichloro-2-aza-1,3-diphosphaindanes of the type C

Indexed as

aromaticitybiradicalsheterocyclesmolecule activationphosphorus

Identifiers

PMID33038288
PMCPMC7839750
OpenAlexW3092524263

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.